Celltrion Healthcare Co., Ltd., headquartered in South Korea (KR), is a prominent player in the biopharmaceutical industry, specialising in the development and manufacturing of biosimilars and innovative therapeutics. Founded in 2002, the company has achieved significant milestones, including the successful launch of its first biosimilar, Remsima, which has gained global recognition. With a strong operational presence in Europe, the Americas, and Asia, Celltrion Healthcare focuses on providing high-quality, cost-effective treatment options for various diseases, including autoimmune disorders and cancer. Its core products, characterised by their unique formulation and rigorous quality standards, have positioned the company as a leader in the biosimilar market. Notably, Celltrion has received numerous accolades for its contributions to healthcare, reinforcing its commitment to improving patient outcomes worldwide.
We don't have data for Celltrion Healthcare Co., Ltd., but we can show you information about their parent organization instead.
View parent company